1. Pereira IC, Sátiro Vieira EE, de Oliveira Torres LR, Carneiro da Silva FC, de Castro e Sousa JM, Torres-Leal FL. Bromelain supplementation and inflammatory markers: A systematic review of clinical trials. Clinical nutrition ESPEN. 2023;55:116-27. [DOI:10.1016/j.clnesp.2023.02.028]

2. Radziszewska M, Smarkusz-Zarzecka J, Ostrowska L, Pogodzinski D. Nutrition and Supplementation in Ulcerative Colitis. Nutrients. 2022;14(12). [DOI:10.3390/nu14122469]

3. Raman M, Ghosh S. Diet and Nutrition in IBD-Progress and Gaps. Nutrients. 2019;11(7). [DOI:10.3390/nu11081740]

4. Borowitz SM. The epidemiology of inflammatory bowel disease: Clues to pathogenesis? Front Pediatr. 2022;10:1103713. [DOI:10.3389/fped.2022.1103713]

5. M'Koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Pharmaceutical Management. Med Res Arch. 2023;11(1). [DOI:10.18103/mra.v11i1.3135]

6. Keshteli AH, Madsen KL, Dieleman LA. Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions. Nutrients. 2019;11. [DOI:10.3390/nu11071498]

7. Narimani B, Sadeghi A, Daryani NE, Shahrokh S, Nilghaz M, Ghods M, et al. Effectiveness of a novel diet in attenuation of clinical activity of disease in patients with ulcerative colitis: a randomized, clinical trial. Scientific Reports. 2024;14 [DOI:10.1038/s41598-024-64512-8]

8. Melgaard D SJ, Riis J, Ovesen TS, Leutscher P, Sorensen S, et al. Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome: A Feasibility Study. . Nutrients 2022;14 [DOI:10.3390/nu14061296]

9. Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16(1):26-42. [DOI:10.5217/ir.2018.16.1.26]

10. Morshedzadeh N, Shahrokh S, Aghdaei HA, Amin Pourhoseingholi M, Chaleshi V, Hekmatdoost A, et al. Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis. Complementary Therapies in Medicine. 2019;46:36-43. [DOI:10.1016/j.ctim.2019.07.012]

11. Hekmatdoost A, Wu X, Morampudi V, Innis SM, Jacobson K. Dietary oils modify the host immune response and colonic tissue damage following Citrobacter rodentium infection in mice. American Journal of Physiology - Gastrointestinal and Liver Physiology. 2013;304(10):G917-G28. [DOI:10.1152/ajpgi.00292.2012]

12. Karimi S, Tabataba-Vakili S, Yari Z, Alborzi F, Hedayati M, Ebrahimi-Daryani N, et al. The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status. Nutrition Journal. 2019;18(1). [DOI:10.1186/s12937-019-0441-7]

13. Nikkhah-Bodaghi M, Darabi Z, Agah S, Hekmatdoost A. The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis. Phytotherapy Research. 2019;33(4):1027-32. [DOI:10.1002/ptr.6296]

14. Shengjie Huang a, Min Zhang a, b, 1, Xiaoge Li a, Jierong Pei a, Zhirong Zhou a, Peng Lei a,, Meng Wang a PZa, Heshui Yu a, Guanwei Fan a, Lifeng Han a, c, Haiyang Yu a, c,, Yuefei Wang a b, Miaomiao Jiang a, b, *. Formulation, characterization, and evaluation of curcumin-loaded ginger-derived nanovesicles for anti-colitis activity. Journal of Pharmaceutical Analysis. 2024;14(101014). [DOI:10.1016/j.jpha.2024.101014]

15. Özge Erol Do˘gan 1, * , Kezban Esen Karaca Çelik 3, Murat Ba¸s 3 , Eyüp Hakan Alan 4 and Yasir Furkan Ça˘gın 5. Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial. nutrients. 2024;17(1879).

16. Brigida Barberio 1, *,†, Luisa Bertin 1,2,† , Sonia Facchin 1,2 , Erica Bonazzi 1,2, Sara Cusano 1,2, Giulia Romanelli 3,, Francesco Francini Pesenti 3 EC, Paola Palestini 4,5 , Fabiana Zingone 1,2, and Edoardo Vincenzo Savarino 1, *. Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions. Nutrients. 2025;17(1879).

17. Fang Li1, Yanhui Han1,#, Xiaokun Cai1, Min Gu1, Jin Sun1,2, Qi Ce1,2, Tim Goulette1, Mingyue Song1,3, Zhengze Li1, Hang Xiao1,*. Dietary Resveratrol Attenuated Colitis and Modulated Gut Microbiota in Dextran Sulfate Sodium-treated mice. Food Funct. 2020;11:1963-073.

18. Lize Zhang, Hui Xue, Gang Zhao, Cuixia Qiao, Xiaomei Sun, Chengjian Pang, Dianliang Zhang. Curcumin and resveratrol suppress dextran sulfate sodium‑induced colitis in mice. MOLECULAR MEDICINE REPORTS. 2019;19:3053-60. [DOI:10.3892/mmr.2019.9974]

19. Alireza Milajerdi1, Omid Sadeghi1,2, Seyed Davar Siadat3, Seyed Ali Keshavarz4, Alireza Sima5, Homayoon Vahedi5,, Peyman Adibi6 and Ahmad Esmaillzadeh2, 8. A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides,monosaccharides, and polyols on theintestinal microbiome and inflammation inpatients with ulcerative colitis: studyprotocol for a randomized controlled trial. BMC. 2020:2-7.

20. Hikisz P, Bernasinska-Slomczewska J. Beneficial Properties of Bromelain. Nutrients. 2021;13(12). [DOI:10.3390/nu13124313]

21. Agrawal P, Nikhade P, Patel A, Mankar N, Sedani S. Bromelain: A Potent Phytomedicine. Cureus. 2022;14(7):e27876. [DOI:10.7759/cureus.27876]

22. Zhou Z, Wang L, Feng P, Yin L, Wang C, Zhi S, et al. Inhibition of Epithelial TNF-alpha Receptors by Purified Fruit Bromelain Ameliorates Intestinal Inflammation and Barrier Dysfunction in Colitis. Front Immunol. 2017;8:1468. [DOI:10.3389/fimmu.2017.01468]

23. Hale LP, Greer PK, Trinh CT, Gottfried MR. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin Immunol. 2005;116(2):135-42. [DOI:10.1016/j.clim.2005.04.011]

24. Madkhali1 JY, , Rasha H. Hussein1, Alnahdi3 HS. Therapeutic effect of bromelain and papain on intestinal injury induced by indomethacin in male rats. International Journal of Health Sciences. 2023;17:23_30.

25. Jane E. Onken MD, M.H.S., Paula K. Greer, B.S., Brian Calingaert, M., M.BMA., and, Laura P. Hale MD, Ph.D. Bromelain Treatment Decreases Secretion of Pro-Inflammatory

26. Cytokines and Chemokines by Colon Biopsies In Vitro. Clin Immunol. 2008;126:345_52. [DOI:10.1016/j.clim.2007.11.002]

27. Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. Ulcerative colitis. Nature Reviews Disease Primers. 2020;6(1):74. [DOI:10.1038/s41572-020-0205-x]

28. Kane S, Goldberg MJ. Use of Bromelain for Mild Ulcerative Colitis. Annals of Internal Medicine. 2000;132(7):680. [DOI:10.7326/0003-4819-132-8-200004180-00026]

29. Onken JE, Greer PK, Calingaert B, Hale LP. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin Immunol. 2008;126(3):345-52. [DOI:10.1016/j.clim.2007.11.002]

30. Kansakar U, Trimarco V, Manzi MV, Cervi E, Mone P, Santulli G. Exploring the Therapeutic Potential of Bromelain: Applications, Benefits, and Mechanisms. Nutrients. 2024;16(13). [DOI:10.3390/nu16132060]

31. Tratenšek A, Locatelli I, Grabnar I, Drobne D, Vovk T. Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis. Redox Biol. 2024;77:103380. [DOI:10.1016/j.redox.2024.103380]

32. Muro P, Zhang L, Li S, Zhao Z, Jin T, Mao F, et al. The emerging role of oxidative stress in inflammatory bowel disease. Frontiers in Endocrinology. 2024;Volume 15 - 2024. [DOI:10.3389/fendo.2024.1390351]

33. Hale LP, Chichlowski M, Trinh CT, Greer PK. Dietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis. Inflamm Bowel Dis. 2010;16(12):2012-21. [DOI:10.1002/ibd.21320]

34. Walmsley R, Ayres R, Pounder R, Allan R. A simple clinical colitis activity index. Gut. 1998;43(1):29 [DOI:10.1136/gut.43.1.29]